SWOG clinical trial number
CTSU/A011502
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Open
Phase
Abbreviated Title
The ABC Trial: Rando PIII Double Blind Placebo/Aspirin for Node+ / HER2- Breast Cancer
Status Notes
This study is active in SWOG effective 4/15/17.
Activated
04/15/2017
Participants
CTSU
Research committees
Breast Cancer
Treatment
Aspirin
Eligibility Criteria Expand/Collapse
Publication Information Expand/Collapse
Other Clinical Trials
CTSU-A012301
SWOG Clinical Trial Number
Research Committee(s)
Breast Cancer
Activated
02/05/2025
Open
Phase
S2206
SWOG Clinical Trial Number
Research Committee(s)
Breast Cancer
Symptom Control and Quality of Life
Activated
10/30/2023
21% Accrual
Accrual
21%
Open
Phase
S2212
SWOG Clinical Trial Number
Research Committee(s)
Breast Cancer
Activated
07/21/2023
31% Accrual
Accrual
31%
Open
Phase